SCHEMBL50136

SCHEMBL50136

CS(=O)(=O)NCc1ccc2c(c1)S(=O)(=O)N=C(CC(=O)O)N2

nearest known ligand 0.41

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KMT2A Q03164 2/20 0.41
ALDH1A1 P00352 5/20 0.40
PKM P14618 2/20 0.38
MAPT P10636 1/20 0.38
TSHR P16473 3/20 0.37
KDM4E B2RXH2 2/20 0.37
POLB P06746 1/20 0.37
RECQL P46063 1/20 0.37
LMNA P02545 3/20 0.36
CYP3A4 P08684 2/20 0.35
CYP2D6 P10635 2/20 0.35
SMN1; SMN2 Q16637 2/20 0.35
MEN1 O00255 1/20 0.35
NR1I2 O75469 1/20 0.35
ABCB11 O95342 1/20 0.35
ADRA2A P08913 1/20 0.35
CYP2C9 P11712 1/20 0.35
ADRA2B P18089 1/20 0.35
ADRA2C P18825 1/20 0.35
THRB P10828 3/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL49931 0.82 ALDH1A1 (0.41) KMT2AALDH1A1PKMTSHRKDM4E
SCHEMBL13418829 0.78 ALDH1A1 (0.40) KMT2AALDH1A1PKMMAPTTSHR
SCHEMBL14338091 0.77 ALDH1A1 (0.47) KMT2AALDH1A1PKMMAPTTSHR
SCHEMBL3389367 0.76 ALDH1A1 (0.45) KMT2AALDH1A1PKMMAPTTSHR
SCHEMBL13712963 0.74 ALDH1A1 (0.44) KMT2AALDH1A1PKMMAPTTSHR
SCHEMBL3392351 0.74 MAPT (0.46) KMT2AALDH1A1MAPTTSHRKDM4E
SCHEMBL14242094 0.72 ALDH1A1 (0.40) ALDH1A1MAPTTSHRPOLBRECQL
Ether SCHEMBL6234273 0.71 ALDH1A1 (0.42) KMT2AALDH1A1MAPTTSHRRECQL
SCHEMBL390919 0.71 ALDH1A1 (0.65) KMT2AALDH1A1PKMMAPTPOLB
SCHEMBL15884036 0.71 CYP1A2 (0.44) KMT2AALDH1A1MAPTKDM4EPOLB

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8129368-B2 5,6-dihydro-1H-pyridin-2-one compounds ANADYS PHARMACEUTICALS, INC. (US) 2012-03-06 US disclosed
US-20100119481-A1 5,6-DIHYDRO-1H-PYRIDIN-2-ONE COMPOUNDS ANADYS PHARMACEUTICALS, INC. (US) 2010-05-13 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100119481-A1 5,6-DIHYDRO-1H-PYRIDIN-2-ONE COMPOUNDS HAVCR2, PYGL, HCCS KMT2A 4654/4885ALDH1A1 417/4885PKM 1283/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.